We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)
References
Bibliografía
1
Fahy, TMarked improvement in tardive dyskinesia following treatment with olanzapine in an elderly subject. Br J Psychiatry1998; 172: 86.Google Scholar
2
Guy, WECDEU Assessment Manual for Psychopharma-cology. Washington, DC: US Department of Health, Education and Welfare; 1976.Google Scholar
3
Lieberman, JASaltz, BLJohns, CAPollack, SBorenstein, MKane, JThe effects of clozapine on tardive dyskinesia. Br J Psychiatry1991; 158: 503–10.CrossRefGoogle ScholarPubMed
4
Littrell, KHJohnson, CGLittrell, SPeabody, CDMarked reduction of tardive dyskinesia with olanzapine. Arch Gen Psychiatry1998; 55: 279–80.CrossRefGoogle ScholarPubMed
5
Lykouras, LMalliori, MChristodoulou, GNImprovement of tardive dyskinesia following treatment with olanzapine. Eur Neuropsychopharmacol1999; 9: 367–8.Google ScholarPubMed
6
Soutullo, CAKeck, PEMcElroy, SLOlanzapine in the treatment of tardive dyskinesia: a report of two cases. J Clin Psychopharmacol1999; 19: 100–1.CrossRefGoogle ScholarPubMed
7
Tollefson, GDBeasley, CM JrTamura, RNTran, PVPotvin, JHBlind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry1997; 154: 1248–54.Google ScholarPubMed
8
Zarate, CAJrNarendan, RTohen, MGreaney, JJBerman, APike, Set al. Clinical predictors of acute response with olanzapine in psychotic mood disorders. J Clin Psychiatry1998; 59: 24–8.CrossRefGoogle ScholarPubMed